A detailed history of Fluent Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fluent Financial, LLC holds 21,854 shares of ABBV stock, worth $3.75 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
21,854
Previous 25,150 13.11%
Holding current value
$3.75 Million
Previous $4.31 Million 0.05%
% of portfolio
2.1%
Previous 2.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$163.84 - $199.33 $540,016 - $656,991
-3,296 Reduced 13.11%
21,854 $4.32 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $397,810 - $464,553
2,570 Added 11.38%
25,150 $4.31 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $475,784 - $542,111
-2,977 Reduced 11.65%
22,580 $4.11 Million
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $125,353 - $141,177
-911 Reduced 3.44%
25,557 $3.96 Million
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $3.54 Million - $4.09 Million
26,468 New
26,468 $3.95 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fluent Financial, LLC Portfolio

Follow Fluent Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fluent Financial, LLC with notifications on news.